MYC and mantle cell lymphoma: For instance, Zhang et al. demonstrated that resistant mantle cell lymphoma (MCL) exhibited a progressive increase in oxidative phosphorylation (OXPHOS), MYC signalling, mTORC1 activation, and G2/M checkpoint deregulation [57].